Assessing bone quality in breast cancer patients during mammograms
Official title: Bone Quality Assessment During Breast Cancer Treatment via Wrist Tomosynthesis in the Mammography Setting
Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11106808 · Data updated 2026-11-12
This study is looking at how certain breast cancer treatments might impact bone health, and it’s designed for patients receiving these treatments, so they can get their bone health checked easily during their regular mammogram visits without any extra stress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project start | June 16, 2025 |
| Project end | May 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $651,514 |
| NIH project number | 1R01AR085637-01 |
| Project ID | NIH-11106808 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are breast cancer patients undergoing treatment with aromatase inhibitors, particularly those who are postmenopausal.
✕Less likely to help
Patients who are not receiving aromatase inhibitors or those with other types of breast cancer may not benefit from this research.
What this research studies
This research investigates how breast cancer treatments, particularly aromatase inhibitors, affect bone quality in patients. By using wrist tomosynthesis during routine mammography appointments, the study aims to identify bone loss that may not be detected by standard imaging methods. This approach allows for simultaneous monitoring of bone health without requiring additional appointments, which can be stressful for patients. The goal is to better understand the patterns of bone loss in different patient demographics and improve care for those at risk of fractures.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and management of bone health in breast cancer patients, reducing the risk of fractures.
How similar studies have gone: Other research has shown promise in using advanced imaging techniques to assess bone health, suggesting that this approach could be effective.
Where this research is happening
-
Henry Ford Health + Michigan State University Health Sciences
East Lansing, United States Active
Researchers
- Principal investigator: Yeni, Yener N — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Yeni, Yener N
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.